Avicanna Inc. (“Avicanna ” or “Company” ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the ...
Using AI to assemble real-world COPD data can help to identify specific clinical traits faster and with greater accuracy than traditional data sources This collaboration supports Tessel's drug ...
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...
The award, supported by diabetes and obesity pharma giant Eli Lilly and Company, validates the calibre of Tap Health’s ...
The Boise State College of Health Sciences named Nate Williams (‘02 and ‘04), currently an associate professor in the School ...
Health Connect is evolving beyond fitness, with signs of medical, lifestyle, and symptom tracking that could make Android ...
The Agentic AI Governance Assurance & Trust Engine (AAGATE) translates the high-level functions of NIST AI RMF into a living, Kubernetes-native architecture.
Avicanna’s evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicanna’s 2025 advances across R&D, clinical development, and medical affairs. TORONTO, Dec. 19, 2025 ...
As Canada enters peak respiratory illness season, Canadians now have access to the first Health Canada-approved at-home COVID-19 and Influenza A/B combination test currently available to consumers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback